Company intelligence / Profile preview

MediSpectra

Lexington, Massachusetts, United Statesmedispectra.com ↗

Ownership: Private
Development stage: Other

Overview

MediSpectra was a medical technology company focused on developing and commercializing advanced optical spectroscopy systems for the early detection of cancer. The company's primary product, the LUMA Cervical Imaging System, utilized tissue fluorescence and reflectance spectroscopy to identify precancerous lesions in the cervix. By providing real-time, non-invasive diagnostic information, MediSpectra aimed to improve the accuracy of traditional screening methods like the Pap test and colposcopy. The company's assets and intellectual property were acquired by SpectraScience in 2007.

Therapeutic areas: OncologyGastroenterology
Modalities: Device
Industry: Medical Imaging

Beyond the preview

Go deeper on MediSpectra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MediSpectra.

Explore the full profile